Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD
Clinical trial NCT03584295 · TERMINATED
Trial details
- NCT number
- NCT03584295
- Sponsor
- Xenios AG
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2024-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.